Literature DB >> 16144535

Ultimate success in epilepsy--the patient's perspective.

J W Sander1.   

Abstract

Most people with epilepsy can live outwardly normal lives, but fear about impending seizures, driving restrictions, lack of independence, employment and social problems, medication-related adverse effects and the presence of cognitive or psychiatric complications are all concerns readily identified by affected individuals. While seizure control is the overriding goal of treatment, it is essential to realize the importance that patients place on other aspects of daily functioning. While many of the concerns identified by patients can only be managed by improved social support, others (e.g. neuropsychological impairment, medication-related adverse events, cognitive impairment, sleep disturbance) may be amenable to therapy (if available) or to the selection of a more appropriate antiepileptic drug. Each antiepileptic drug has a unique pharmacodynamic and tolerability profile. Awareness by the treating clinician of the pharmacological profile of each drug may help to minimize unwanted treatment-related effects and possibly improve the outcome of treatment from an epilepsy patient's perspective. Therefore, in order to achieve true treatment success, clinicians need to understand how individuals perceive their disorder and, where possible, address those factors that adversely affect patient quality of life. For the person with epilepsy, successful treatment involves beneficial effects on social, vocational and psychological function. This extends beyond seizure control to freedom from the fear associated with seizures, confidence in pharmacological therapy and improvements in health-related quality of life.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16144535     DOI: 10.1111/j.1468-1331.2005.01326.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  7 in total

1.  Current Principles in the Management of Drug-Resistant Epilepsy.

Authors:  Nathan A Shlobin; Josemir W Sander
Journal:  CNS Drugs       Date:  2022-05-20       Impact factor: 6.497

2.  Global campaign against epilepsy: assessment of a demonstration project in rural China.

Authors:  Wenzhi Wang; Jianzhong Wu; Xiuying Dai; Guangyu Ma; Bin Yang; Taiping Wang; Chenglin Yuan; Ding Ding; Zhen Hong; Patrick Kwan; Gail S Bell; Leonid L Prilipko; Hanneke M de Boer; Josemir W Sander
Journal:  Bull World Health Organ       Date:  2008-12       Impact factor: 9.408

3.  "There Are Hills and Valleys": Experiences of Parenting a Son With X-Linked Retinoschisis.

Authors:  Amy Turriff; Rosalie Nolen; Celeste D'Amanda; Barbara Biesecker; Catherine Cukras; Paul A Sieving
Journal:  Am J Ophthalmol       Date:  2019-11-23       Impact factor: 5.258

4.  Systematic Adverse Drug Reaction Monitoring of Patients Under Newer Antiepileptic Drugs Using Routine Clinical Data of Inpatients.

Authors:  Annika Hilgers; Marion Schaefer
Journal:  Drugs Real World Outcomes       Date:  2016-05-25

5.  Concerns with AED conversion: comparison of patient and physician perspectives.

Authors:  Brien J Smith; Erik K St Louis; John M Stern; Chad Green; Thomas Bramley
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

6.  Managing patient adherence and quality of life in epilepsy.

Authors:  Joanne Eatock; Gus A Baker
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

7.  Antiepileptic drug utilization in Bangladesh: experience from Dhaka Medical College Hospital.

Authors:  Mansur Habib; Sharif Uddin Khan; Azhahul Hoque; Badrul Alam Mondal; A T M Hasibul Hasan; Rajib Nayan Chowdhury; Badrul Haque; Kazi Mohibur Rahman; Ahmed Hossain Chowdhury; Swapon Kumar Ghose; Quazi Deen Mohammad
Journal:  BMC Res Notes       Date:  2013-11-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.